Chief Investment Officer Eric W. Bennett Hosts Michael Gregory for a Special Edition of Inside the Investment

June 11, 2020 - Investment Management
1 Min read

Chief Investment Officer Eric W. Bennett and Tolleson Wealth Management’s Investment Team hosted a virtual interview featuring Michael Gregory to discuss investing in biotechnology amid a pandemic. Gregory is Co-Managing Partner and Co-Founder of Avidity Partners, serving as Director of Research and President. For more than a decade, he has been a respected healthcare investor and is a member of several prestigious boards, including UT Southwestern here in Dallas.

Gregory discussed the long-term implications for biotechnology investors as a result of the spotlight the global pandemic is shining on this sector. “Our clients were able to hear a unique and educated perspective on how biotech companies are balancing scientific discovery with future profitability,” says Investments Director Sarah Wiewel. “Health and life sciences investing is a timely topic right now and the risk-managed, healthcare strategy is well-positioned given the current public health crisis.”

This event is one of many in a series dedicated to going “inside the investment” to give clients the unique opportunity to learn more about strategies within portfolios. Other previous events like this have featured topics such as frontier markets, junk bonds, and real estate. Bennett, along with the rest of the Tolleson Wealth Management Investment Team, continues to stay informed on hot trends and impacts to the economy. Especially during the current global pandemic, the team leverages its expertise to connect clients with information and investment opportunities that align with their goals.